Stock Based Compensation (Tables)

6 Months Ended

Mar. 31, 2017

Schedule Of Stock Compensation Expense [Table Text Block]

Stock compensation expense for the three and six months ended March 31, 2017 and 2016 is as follows:

	Three Months Ended		Three Months Ended
Stock Compensation Expense	March 31, 2017		March 31, 2016
Stock Grants	$	84,000	$	102,000
Restricted Stock Grants		13,000		11,000
Option Grants		13,000		10,000
Employee Stock Purchase Plan		1,000		1,000
Subsidiary Option Grants		28,000		19,000
Total	$	139,000	$	143,000

	Six Months Ended		Six Months Ended
Stock Compensation Expense	March 31, 2017		March 31, 2016
Stock Grants	$	123,000	$	185,000
Restricted Stock Grants		26,000		19,000
Option Grants		25,000		17,000
Employee Stock Purchase Plan		1,000		1,000
Subsidiary Option Grants		52,000		40,000
Total	$	227,000	$	262,000

Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]

A summary of restricted stock activity for the six months ended March 31, 2017 is presented below:

Restricted Stock Activity for the Six Months ended			Weighted-Average
March 31, 2017	Shares		Grant-Date Fair Value
Nonvested at September 30, 2016		100,000	$	1.73
Granted		-		-
Vested		(30,000)		1.73
Cancelled		-		-
Nonvested and expected to vest at March 31, 2017		70,000	$	1.73

Stock Option Grants [Member]

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

The weighted average assumptions used in the Black-Scholes option pricing model for the stock option grant during the six months ended March 31, 2017 were as follows:

	Six Months
	Ended March 31,
	2017
Expected term in years		3 years
Risk-free interest rate		1.48	%
Expected volatility		69.57	%
Expected dividend yield		0.00	%

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

A summary of stock option activity for the six months ended March 31, 2017 is presented below:

			Weighted Average		Weighted Average
	Options		Exercise Price per		Remain Contractual
	Outstanding		Share		Term (in Years)
Balance at September 30, 2016		123,147	$	2.30		1.69
Outstanding and exercisable at September 30, 2016		123,147	$	2.30		1.69
Granted		95,602		1.80		2.84
Exercised		-		-
Cancelled		(21,980)		3.03
Balance at March 31, 2017		196,769	$	1.98		2.14
Outstanding and exercisable at March 31, 2017		196,769	$	1.98		2.14

Subsidiary Option Grants [Member]

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]

These options were valued using the Black-Scholes option pricing model and the assumptions for that were as follows:

Expected term in years	10 years
Risk-free interest rate	2.42	%
Expected volatility	83.11	%
Expected dividend yield	0.00	%

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]

A summary of Xcede stock option activity for the six months ended March 31, 2017 is presented below:

			Weighted Average		Weighted Average
	Options		Exercise Price per		Remain Contractual
	Outstanding		Share		Term (in Years)
Balance at September 30, 2016		613,653	$	1.00		8.35
Outstanding and exercisable at September 30, 2016		320,586		1.00		8.01
Granted		810,500		1.00
Exercised		-		-
Cancelled		(48,197)		1.00
Balance at March 31, 2017		1,375,956		1.00		9.22
Outstanding and exercisable at March 31, 2017		730,694	$	1.00		8.62